SEC Info - Eloxx Pharmaceuticals, Inc. - ‘8-K’ for 9/14/22

SEC Info℠

Home

Help

Please Sign In

Eloxx Pharmaceuticals, Inc. – ‘8-K’ for 9/14/22 – ‘XML’

On: Thursday, 9/15/22, at 8:07am ET · For: 9/14/22 · Accession #: 1104659-22-100245 · File #: 1-31326

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/15/22  Eloxx Pharmaceuticals, Inc.       8-K:7,8,9   9/14/22   12:3.5M                                   Toppan Merrill/FA

Current Report — Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     36K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     20K 
 3: EX-99.2     Miscellaneous Exhibit                               HTML     21K 
 7: R1          Cover                                               HTML     46K 
10: XML         IDEA XML File -- Filing Summary                      XML     12K 
 8: XML         XBRL Instance -- tm2225930d1_8k_htm                  XML     15K 
 9: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 5: EX-101.LAB  XBRL Labels -- elox-20220914_lab                     XML     97K 
 6: EX-101.PRE  XBRL Presentations -- elox-20220914_pre              XML     64K 
 4: EX-101.SCH  XBRL Schema -- elox-20220914                         XSD     12K 
11: JSON        XBRL Instance as JSON Data -- MetaLinks               25±    33K 
12: ZIP         XBRL Zipped Folder -- 0001104659-22-100245-xbrl      Zip     32K

‘XML’ — XBRL Instance — tm2225930d1_8k_htm

This Document is an XBRL XML File.

<?xml version="1.0" encoding="windows-1252"?>

<link:schemaRef xlink:href="elox-20220914.xsd" xlink:type="simple"/>

</entity>

</period>

</context>

</unit>

<measure> shares </measure>

</unit>

</unitNumerator>

<measure> shares </measure>

</unitDenominator>

</divide>

</unit>

<dei:EntityCentralIndexKey contextRef="From2022-09-14to2022-09-14"> 0001035354 </dei:EntityCentralIndexKey>

<dei:AmendmentFlag contextRef="From2022-09-14to2022-09-14"> false </dei:AmendmentFlag>

<dei:DocumentType contextRef="From2022-09-14to2022-09-14"> 8-K </dei:DocumentType>

<dei:DocumentPeriodEndDate contextRef="From2022-09-14to2022-09-14"> 2022-09-14 </dei:DocumentPeriodEndDate>

<dei:EntityRegistrantName contextRef="From2022-09-14to2022-09-14"> Eloxx Pharmaceuticals, Inc. </dei:EntityRegistrantName>

<dei:EntityIncorporationStateCountryCode contextRef="From2022-09-14to2022-09-14"> DE </dei:EntityIncorporationStateCountryCode>

<dei:EntityFileNumber contextRef="From2022-09-14to2022-09-14"> 001-31326 </dei:EntityFileNumber>

<dei:EntityTaxIdentificationNumber contextRef="From2022-09-14to2022-09-14"> 84-1368850 </dei:EntityTaxIdentificationNumber>

<dei:EntityAddressAddressLine1 contextRef="From2022-09-14to2022-09-14"> 480 Arsenal Way, Suite 130 </dei:EntityAddressAddressLine1>

<dei:EntityAddressCityOrTown contextRef="From2022-09-14to2022-09-14"> Watertown </dei:EntityAddressCityOrTown>

<dei:EntityAddressStateOrProvince contextRef="From2022-09-14to2022-09-14"> MA </dei:EntityAddressStateOrProvince>

<dei:EntityAddressPostalZipCode contextRef="From2022-09-14to2022-09-14"> 02451 </dei:EntityAddressPostalZipCode>

<dei:CityAreaCode contextRef="From2022-09-14to2022-09-14"> 781 </dei:CityAreaCode>

<dei:LocalPhoneNumber contextRef="From2022-09-14to2022-09-14"> 577-5300 </dei:LocalPhoneNumber>

<dei:WrittenCommunications contextRef="From2022-09-14to2022-09-14"> false </dei:WrittenCommunications>

<dei:SolicitingMaterial contextRef="From2022-09-14to2022-09-14"> false </dei:SolicitingMaterial>

<dei:PreCommencementTenderOffer contextRef="From2022-09-14to2022-09-14"> false </dei:PreCommencementTenderOffer>

<dei:PreCommencementIssuerTenderOffer contextRef="From2022-09-14to2022-09-14"> false </dei:PreCommencementIssuerTenderOffer>

<dei:Security12bTitle contextRef="From2022-09-14to2022-09-14"> Common Stock, $0.01 par value per share </dei:Security12bTitle>

<dei:TradingSymbol contextRef="From2022-09-14to2022-09-14"> ELOX </dei:TradingSymbol>

<dei:SecurityExchangeName contextRef="From2022-09-14to2022-09-14"> NASDAQ </dei:SecurityExchangeName>

<dei:EntityEmergingGrowthCompany contextRef="From2022-09-14to2022-09-14"> false </dei:EntityEmergingGrowthCompany>

</xbrl>

↑Top

Filing Submission 0001104659-22-100245 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Eloxx Pharmaceuticals, Inc. – ‘8-K’ for 9/14/22 – ‘XML’

On: Thursday, 9/15/22, at 8:07am ET · For: 9/14/22 · Accession #: 1104659-22-100245 · File #: 1-31326

Previous ‘8-K’: ‘8-K’ on / for 8/15/22 · Next: ‘8-K’ on 10/14/22 for 10/11/22 · Latest: ‘8-K’ on 3/29/24 for 3/25/24

Current Report — Form 8-KFiling Table of Contents

‘XML’ — XBRL Instance — tm2225930d1_8k_htm

This Document is an XBRL XML File.

Current Report — Form 8-K

Filing Table of Contents